Gold Colloid Co., a leading distributor of medical and diagnostic products in the United States, announced today a strategic partnership with Hangzhou Clongene Biotech Co., Ltd., a renowned Chinese manufacturer of in-vitro diagnostic (IVD) rapid tests and raw materials.
La Mesa, CA – January 12, 2024 – Gold Colloid Co., a leading distributor of medical and diagnostic products in the United States, announced today a strategic partnership with Hangzhou Clongene Biotech Co., Ltd., a renowned Chinese manufacturer of in-vitro diagnostic (IVD) rapid tests and raw materials. This collaboration will bring Clongene’s innovative and high-quality products to the US market, expanding access to crucial rapid testing solutions for healthcare providers and patients nationwide.
Under the terms of the agreement, Gold Colloid will become the distributor of Clongene’s rapid IVD tests across a wide range of categories, including drug of abuse, fertility, and pregnancy testing. These tests are known for their accuracy, rapid results, and ease of use, making them ideal for point-of-care settings and at-home testing. Additionally, Gold Colloid will distribute Clongene’s raw materials, enabling US manufacturers to produce their own high-quality IVD tests domestically.
“We are thrilled to partner with Clongene to bring their cutting-edge rapid testing solutions to the US,” said Daniel Levenson, CEO of Gold Colloid Co. “Clongene’s commitment to quality and innovation aligns perfectly with our values, and we believe their products will play a vital role in improving healthcare access and outcomes across the country.”
The partnership between Gold Colloid and Clongene comes at a critical time, as the demand for rapid IVD testing remains high due to the ongoing COVID-19 pandemic and the increasing prevalence of other infectious diseases. This collaboration holds the potential to significantly impact the US healthcare system by providing faster and more convenient testing options, ultimately leading to improved patient care and public health outcomes.
About Gold Colloid Co.
Gold Colloid Co. is a leading distributor of medical and diagnostic products in the United States. The company has been serving the healthcare community for over [Number] years, providing high-quality products and exceptional customer service. Gold Colloid is committed to providing healthcare providers with the tools they need to deliver the best possible care to their patients.
About Hangzhou Clongene Biotech Co., Ltd.
Hangzhou Clongene Biotech Co., Ltd. is a leading manufacturer of in-vitro diagnostic (IVD) rapid tests and raw materials in China. The company is dedicated to developing and producing high-quality, accurate, and easy-to-use rapid tests for a wide range of applications. Clongene is committed to improving healthcare access and outcomes through its innovative IVD solutions.
Contact:
Daniel Levenson CEO Gold Colloid Co. d.levenson@goldcolloid.com